Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole in Japanese NERD patients
NCT00259077Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2003
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of omeprazole in non-erosive reflux disease (NERD) (3 arms), sponsored by AstraZeneca. Primary endpoint: Complete resolution rate of heartburn at 4 weeks. Started Oct 2003; status: completed.
02
Drugs
omeprazole
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT00259077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259077.